Non-coding RNA-mediated autophagy in cancer: A protumor or antitumor factor?

Biochim Biophys Acta Rev Cancer. 2021 Dec;1876(2):188642. doi: 10.1016/j.bbcan.2021.188642. Epub 2021 Oct 27.

Abstract

Autophagy, usually referred to as macroautophagy, is a cytoprotective behavior that helps cells, especially cancer cells, escape crises. However, the role of autophagy in cancer remains controversial. The induction of autophagy is favorable for tumor growth, as it can degrade damaged cell components accumulated during nutrient deficiency, chemotherapy, or other stresses in a timely manner. Whereas the antitumor effect of autophagy might be closely related to its crosstalk with metabolism, immunomodulation, and other pathways. Recent studies have verified that lncRNAs and circRNAs modulate autophagy in carcinogenesis, cancer cells proliferation, apoptosis, metastasis, and chemoresistance via multiple mechanisms. A comprehensive understanding of the regulatory relationships between ncRNAs and autophagy in cancer might resolve chemoresistance and also offer intervention strategies for cancer therapy. This review systematically displays the regulatory effects of lncRNAs and circRNAs on autophagy in the contexts of cancer initiation, progression, and resistance to chemo- or radiotherapy and provides a novel insight into cancer therapy.

Keywords: Antitumor; Autophagy; Cancer progression; Non-coding RNA; Protumor; Resistance.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Autophagy / genetics*
  • Humans
  • Neoplasms / genetics*
  • Neoplasms / pathology
  • RNA, Untranslated / metabolism*

Substances

  • RNA, Untranslated